Literature DB >> 7671349

Hypertrophic cardiomyopathy. Clinical spectrum and treatment.

E D Wigle1, H Rakowski, B P Kimball, W G Williams.   

Abstract

HCM is a heterogeneous disease genotypically, phenotypically, pathophysiologically, clinically, and therapeutically. In decisions on the management of these patients, it is important to recognize this heterogeneity and to direct therapy at the predominant abnormalities.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7671349     DOI: 10.1161/01.cir.92.7.1680

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  112 in total

1.  An equation to predict the changes in peak left ventricular pressure in hypertrophic obstructive cardiomyopathy after treatment: application to the administration of disopyramide.

Authors:  K Niki; M Sugawara; S Tanino; K Iwade; S Hosoda; H Kasanuki
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

Review 2.  Current status of alcohol septal ablation for patients with hypertrophic cardiomyopathy.

Authors:  H Seggewiss
Journal:  Curr Cardiol Rep       Date:  2001-03       Impact factor: 2.931

Review 3.  Cardiomyopathy: The diagnosis of hypertrophic cardiomyopathy.

Authors:  E D Wigle
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

Review 4.  Medical treatment of hypertrophic cardiomyopathy.

Authors:  M V Sherrid; D Gunsburg; A Sharma
Journal:  Curr Cardiol Rep       Date:  2000-03       Impact factor: 2.931

5.  Hemodynamic effects of isometric exercise in hypertrophic cardiomyopathy: comparison with normal subjects.

Authors:  Quirino Ciampi; Sandro Betocchi; Anna Violante; Raffaella Lombardi; Maria Angela Losi; Giovanni Storto; Fiore Manganelli; Carlo Gabriele Tocchetti; Mariano Aversa; Elpidio Pezzella; Filippo Finizio; Alberto Cuocolo; Massimo Chiariello
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

Review 6.  Non-coronary percutaneous intervention.

Authors:  Ever D Grech
Journal:  BMJ       Date:  2003-07-12

7.  Contemporary considerations for risk stratification, sudden death and prevention in hypertrophic cardiomyopathy.

Authors:  B J Maron
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

8.  Swimming exercise in infancy has beneficial effect on the hearts in cardiomyopathic Syrian hamsters.

Authors:  Mariko Tatsuguchi; Eriko Hiratsuka; Shuichi Machida; Toshio Nishikawa; Shin-Ichiro Imamura; Satoru Shimizu; Masahiko Nishimura; Issei Komuro; Yoshiyuki Furutani; Michiko Furutani; Hiroaki Nagao; Keiko Komatsu; Hiroshi Kasanuki; Rumiko Matsuoka
Journal:  J Muscle Res Cell Motil       Date:  2004       Impact factor: 2.698

9.  Rapid fatty acid ethyl ester synthesis by porcine myocardium upon ethanol infusion into the left anterior descending coronary artery.

Authors:  Danita M Yoerger; Catherine A Best; Brendan M McQuillan; Gregory E Supple; J Luis Guererro; Joanne E Cluette-Brown; Ali Hasaba; Michael H Picard; James R Stone; Michael Laposata
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

Review 10.  Management of hypertrophic cardiomyopathy in children.

Authors:  Hubert Seggewiss; Angelos Rigopoulos
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.